Investors
 

NASDAQ: TTPH

$ 11.25

0.32 (2.93%)

Day High: 11.45
Day Low:  11.00
Volume:    138,000

1:17 PM ET
Jul 22, 2014



Delayed at least 20 min., by eSignal.


Stock price graph

     

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Tetraphase Pharmaceuticals's financial performance into perspective.

View all »   RSSRecent Releases

Jun 19, 2014
Tetraphase Pharmaceuticals Completes Enrollment in Lead-in Portion of IGNITE 2 Eravacycline Phase 3 Clinical Trial in cUTI

Jun 17, 2014
Tetraphase Pharmaceuticals Adds Dr. Jeffrey Chodakewitz to Board of Directors

View all »Events & Presentations

Jul 29, 2014
3rd Annual BMO Biotech Corporate Access Day

Aug 6, 2014
InvestMNt 2014

Sep 3, 2014
Baird 2014 Health Care Conference